What is BioTeam?
BioTeam operates as a specialized consultancy and implementation partner at the intersection of life sciences and high-performance computing. By providing objective, strategic counsel, the firm enables research-driven organizations to optimize their technological stacks. Their core competency lies in transforming raw scientific data into tangible results through the integration of advanced digital tools and infrastructure. As a key player in the research enablement space, BioTeam serves as a critical bridge for institutions looking to modernize their laboratory workflows and data management capabilities, ensuring that scientific discovery is supported by scalable, efficient, and future-proof technology architectures.
How much funding has BioTeam raised?
BioTeam has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in BioTeam
PPP
Public-Private Partnership
What's next for BioTeam?
Following this late-stage financing, BioTeam is expected to prioritize the expansion of its service delivery capabilities and the deepening of its technical expertise. The strategic allocation of these funds will likely focus on scaling the firm's implementation teams to meet the growing demand for sophisticated research infrastructure. By leveraging this capital, BioTeam aims to solidify its role as an indispensable partner for global research entities, potentially exploring new market segments where high-performance computing and scientific data management are becoming increasingly vital. The focus remains on maintaining high-touch, expert-led consulting while scaling operations to support larger, more complex enterprise-level research initiatives.
See full BioTeam company page
